10.57647/ijm2c.2025.150421

Advanced Computational Design of Targeted Anticancer Peptides Using Docking, Molecular Dynamics, and Deep Learning

  1. Department of Biology, CT.C. Islamic Azad University, Tehran, Iran.
  2. Center for Molecular Medicine, University of Georgia, Athens, USA.

Received: 05-05-2025

Revised: 12-07-2025

Accepted: 26-07-2025

Published in Issue 28-07-2025

How to Cite

Ahmadi, S. F., Samadikhah, H., & Arab, S. S. (2025). Advanced Computational Design of Targeted Anticancer Peptides Using Docking, Molecular Dynamics, and Deep Learning. International Journal of Mathematical Modelling & Computations, 15(4). https://doi.org/10.57647/ijm2c.2025.150421

Abstract

The computational design of peptides is increasingly employed in anticancer drug development, particularly by targeting protein–protein interactions (PPIs). In this study, we utilized structure-based modeling integrated with deep learning approaches, including AlphaFold, to accurately predict peptide structures. The anticancer peptides were designed as conjugates with cell-penetrating peptides (CPPs) to enhance cellular uptake.YASARA was used for structural inspection, and its FoldX plugin enabled the introduction of rational mutations and energy minimization. ChimeraX and AlphaFold were further employed for visualization and structural modeling of the anticancer peptides. The designed peptides were thoroughly evaluated using molecular docking, molecular dynamics (MD) simulations with GROMACS, and binding energy calculations via gmx_MMPBSA. Notably, the mutated peptide demonstrated a significantly improved binding affinity and structural stability compared to the nonmutated peptide, underscoring its potential therapeutic value. Despite the inherent computational complexity, our approach highlights the effectiveness of in silico peptide engineering for developing targeted anticancer therapeutics. Specifically, the designed peptide targets survivin, a member of the inhibitor of apoptosis (IAP) family, which is frequently overexpressed in cancer cells and plays a critical role in tumor progression and therapy resistance. 

Keywords

  • Computational peptide design,
  • Anticancer peptide optimization,
  • Molecular dynamics simulation,
  • Protein-protein docking,
  • Deep learning in structural biology,
  • Mathematical modeling of survivin inhibition,
  • Free energy calculations (MM/PBSA)

References

  1. Alekseenko, A., Ignatov, M., Jones, G., Sabitova, M., & Kozakov, D. (2020). Protein-Protein and Protein-Peptide Docking with ClusPro Server. Methods Mol Biol, 2165, 157-174. https://doi.org/10.1007/978-1-0716-0708-4_9
  2. Blum, B., Bar-Nur, O., Golan-Lev, T., & Benvenisty, N. (2009). The anti-apoptotic gene survivin contributes to teratoma formation by human embryonic stem cells. Nat Biotechnol, 27(3), 281-287. https://doi.org/10.1038/nbt.1527
  3. Buß, O., Rudat, J., & Ochsenreither, K. (2018). FoldX as Protein Engineering Tool: Better Than Random Based Approaches? Comput Struct Biotechnol J, 16, 25-33. https://doi.org/10.1016/j.csbj.2018.01.002
  4. Cai, X., Ma, S., Gu, M., Zu, C., Qu, W., & Zheng, X. (2012). Survivin regulates the expression of VEGF-C in lymphatic metastasis of breast cancer. Diagn Pathol, 7, 52. https://doi.org/10.1186/1746-1596-7-52
  5. Chen, S., Lin, T., Basu, R., Ritchey, J., Wang, S., Luo, Y., Li, X., Pei, D., Kara, L. B., & Cheng, X. (2024). Design of target specific peptide inhibitors using generative deep learning and molecular dynamics simulations. Nature Communications, 15(1), 1611. https://doi.org/10.1038/s41467-024-45766-2
  6. Cheung, C. H. A., Chang, Y. C., Lin, T. Y., Cheng, S. M., & Leung, E. (2020). Anti-apoptotic proteins in the autophagic world: an update on functions of XIAP, Survivin, and BRUCE. J Biomed Sci, 27(1), 31. https://doi.org/10.1186/s12929-020-0627-5
  7. Desta, I. T., Porter, K. A., Xia, B., Kozakov, D., & Vajda, S. (2020). Performance and Its Limits in Rigid Body Protein-Protein Docking. Structure, 28(9), 1071-1081.e1073. https://doi.org/10.1016/j.str.2020.06.006
  8. Fan, Y., & Chen, J. (2017). Clinicopathological significance of survivin expression in patients with cervical cancer: A systematic meta-analysis. Bioengineered, 8(5), 511-523. https://doi.org/10.1080/21655979.2016.1252879
  9. Fang, X. L., Cao, X. P., Xiao, J., Hu, Y., Chen, M., Raza, H. K., Wang, H. Y., He, X., Gu, J. F., & Zhang, K. J. (2024). Overview of role of survivin in cancer: expression, regulation, functions, and its potential as a therapeutic target. J Drug Target, 32(3), 223-240. https://doi.org/10.1080/1061186x.2024.2309563
  10. Filipe, H. A. L., & Loura, L. M. S. (2022). Molecular Dynamics Simulations: Advances and Applications. Molecules, 27(7). https://doi.org/10.3390/molecules27072105
  11. Fuchigami, T., Ishikawa, N., Nozaki, I., Miyanari, Y., Yoshida, S., Yamauchi, M., Soejima, A., Haratake, M., & Nakayama, M. (2020). Discovery of inner centromere protein-derived small peptides for cancer imaging and treatment targeting survivin. Cancer Sci, 111(4), 1357-1366. https://doi.org/10.1111/cas.14330
  12. Garg, H., Suri, P., Gupta, J. C., Talwar, G. P., & Dubey, S. (2016). Survivin: a unique target for tumor therapy. Cancer Cell Int, 16, 49. https://doi.org/10.1186/s12935-016-0326-1
  13. Ghavamipour, F., Shahangian, S., Sajedi, R., Arab, S. S., Mansouri, K., & Aghamaali, M. (2014). Development of highly potent anti-angiogenic VEGF8-109 heterodimer by directed blocking of its VEGFR-2 binding site. FEBS Journal, 281. https://doi.org/10.1111/febs.12956
  14. Hildebrand, P. W., Rose, A. S., & Tiemann, J. K. S. (2019). Bringing Molecular Dynamics Simulation Data into View. Trends Biochem Sci, 44(11), 902-913. https://doi.org/10.1016/j.tibs.2019.06.004
  15. Hollingsworth, S. A., & Dror, R. O. (2018). Molecular Dynamics Simulation for All. Neuron, 99(6), 1129-1143. https://doi.org/10.1016/j.neuron.2018.08.011
  16. Jaiswal, P. K., Goel, A., & Mittal, R. D. (2015). Survivin: A molecular biomarker in cancer. Indian J Med Res, 141(4), 389-397. https://doi.org/10.4103/0971-5916.159250
  17. Jones, G., Jindal, A., Ghani, U., Kotelnikov, S., Egbert, M., Hashemi, N., Vajda, S., Padhorny, D., & Kozakov, D. (2022). Elucidation of protein function using computational docking and hotspot analysis by ClusPro and FTMap. Acta Crystallogr D Struct Biol, 78(Pt 6), 690-697. https://doi.org/10.1107/s2059798322002741
  18. Kato, K., Nakayoshi, T., Kurimoto, E., & Oda, A. (2021). Molecular dynamics simulations for the protein–ligand complex structures obtained by computational docking studies using implicit or explicit solvents. Chemical Physics Letters, 781, 139022. https://doi.org/https://doi.org/10.1016/j.cplett.2021.139022
  19. Kim, P. J., Plescia, J., Clevers, H., Fearon, E. R., & Altieri, D. C. (2003). Survivin and molecular pathogenesis of colorectal cancer. Lancet, 362(9379), 205-209. https://doi.org/10.1016/s0140-6736(03)13910-4
  20. Kozakov, D., Beglov, D., Bohnuud, T., Mottarella, S. E., Xia, B., Hall, D. R., & Vajda, S. (2013). How good is automated protein docking? Proteins, 81(12), 2159-2166. https://doi.org/10.1002/prot.24403
  21. Krzesaj, P., Adler, V., Feinman, R. D., Miller, A., Silberstein, M., Yazdi, E., & Pincus, M. R. (2024). Anti-Cancer Peptide PNC-27 Kills Cancer Cells by Unique Interactions with Plasma Membrane-Bound hdm-2 and with Mitochondrial Membranes Causing Mitochondrial Disruption. Ann Clin Lab Sci, 54(2), 137-148.
  22. Li, C. M., Haratipour, P., Lingeman, R. G., Perry, J. J. P., Gu, L., Hickey, R. J., & Malkas, L. H. (2021). Novel Peptide Therapeutic Approaches for Cancer Treatment. Cells, 10(11). https://doi.org/10.3390/cells10112908
  23. Mirdita, M., Schütze, K., Moriwaki, Y., Heo, L., Ovchinnikov, S., & Steinegger, M. (2022). ColabFold: making protein folding accessible to all. Nature Methods, 19(6), 679-682. https://doi.org/10.1038/s41592-022-01488-1
  24. Naeem, A., Noureen, N., Al-Naemi, S. K., Al-Emadi, J. A., & Khan, M. J. (2024). Computational design of anti-cancer peptides tailored to target specific tumor markers. BMC Chemistry, 18(1), 39. https://doi.org/10.1186/s13065-024-01143-0
  25. Todaro, B., Ottalagana, E., Luin, S., & Santi, M. (2023). Targeting Peptides: The New Generation of Targeted Drug Delivery Systems. Pharmaceutics, 15(6), 1648. https://www.mdpi.com/1999-4923/15/6/1648
  26. Vajda, S., Yueh, C., Beglov, D., Bohnuud, T., Mottarella, S. E., Xia, B., Hall, D. R., & Kozakov, D. (2017). New additions to the ClusPro server motivated by CAPRI. Proteins, 85(3), 435-444. https://doi.org/10.1002/prot.25219
  27. Valdés-Tresanco, M., Valdés-Tresanco, M., Valiente, P., & Moreno Frias, E. (2021). gmx_MMPBSA: A New Tool to Perform End-State Free Energy Calculations with GROMACS. Journal of Chemical Theory and Computation, 17. https://doi.org/10.1021/acs.jctc.1c00645
  28. Wang, L., Wang, N., Zhang, W., Cheng, X., Yan, Z., Shao, G., Wang, X., Wang, R., & Fu, C. (2022). Therapeutic peptides: current applications and future directions. Signal Transduction and Targeted Therapy, 7(1), 48. https://doi.org/10.1038/s41392-022-00904-4
  29. Wu, J., Gao, T., Guo, H., Zhao, L., Lv, S., Lv, J., Yao, R., Yu, Y., & Ma, F. (2023). Application of molecular dynamics simulation for exploring the roles of plant biomolecules in promoting environmental health. Sci Total Environ, 869, 161871. https://doi.org/10.1016/j.scitotenv.2023.161871
  30. Yamashita, T. (2023). Molecular Dynamics Simulation for Investigating Antigen-Antibody Interaction. Methods Mol Biol, 2552, 101-107. https://doi.org/10.1007/978-1-0716-2609-2_4
  31. Zahraee, H., Arab, S. S., Khoshbin, Z., Taghdisi, S. M., & Abnous, K. (2024). Molecular dynamics simulation as a promising approach for computational study of liquid crystal-based aptasensors. J Biomol Struct Dyn, 1-13. https://doi.org/10.1080/07391102.2024.2315326
  32. Zhang, W., & Wang, T. (2023). Bioinformatics-aided Protein Sequence Analysis and Engineering. Curr Protein Pept Sci, 24(6), 477-487. https://doi.org/10.2174/1389203724666230509124300